NAAF Community, Since January 2022, I have had the honor of serving as NAAF’s President & CEO. From the very…
A report recently published in the October 2025 issue of JAMA Dermatology suggests that people with alopecia areata may still benefit from trying a different Janus…
Nektar Therapeutics announced today new results from its Phase 2b REZOLVE-AA study testing rezpegaldesleukin (REZPEG)—an experimental immune-modulating drug—in adults with…
Eli Lilly (Lilly) recently shared 52-week results from its Phase 3 clinical trial examining oral baricitinib (Olumiant®) 4 mg for…
On September 27, the alopecia areata community united for the Walk For AlopeciaTM Presented by Pfizer, coming together at 25 official…
The Board of Directors of the National Alopecia Areata Foundation (NAAF) announced today that Nicole Friedland will retire as President…
The National Alopecia Areata Foundation (NAAF) is thrilled to report that two recent Student Internship Awardees have had their NAAF-supported…
Sun Pharmaceutical Industries Limited (Sun Pharma) today announced LEQSELVI™ (deuruxolitinib) is now commercially available for the treatment of severe alopecia…
Where Is DCC’s Armani Latimer Now? All About the Cheerleader’s Life After Hanging Up Her Uniform Armani Latimer, a retired…
UC Santa Cruz alumni at the forefront of alopecia research and advocacy NAAF President & CEO Nicole Friedland and NAAF…
